The writer is director-general of the International Federation of Pharmaceutical Manufacturers
We all want a coronavirus vaccine. But no matter how urgently action is needed, it is imperative that the highest standards of quality, safety and efficacy are upheld.
Russia’s decision to approve mass use of its “Sputnik 5” vaccine after just two months of human trials is deeply troubling. Efforts by other countries to push through their own candidates at breakneck speed are also problematic.
您已閱讀13%（490字），剩餘87%（3389字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。